跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 139 条关于
“NPDR”
全部
139
临床试验
99
药物
18
机构
0
资讯
22
去年
Ocular Therapeutix Advances AXPAXLI for Wet AMD and Plans NPDR Clinical Trial
去年
Breye Therapeutics Completes Phase 1b Trial of Oral Danegaptide for Early-Stage Diabetic Retinopathy
2年前
Phase 1 HELIOS Trial Shows Promise for OTX-TKI in Non-Proliferative Diabetic Retinopathy
去年
OTX-TKI Shows Promise in Stabilizing Non-Proliferative Diabetic Retinopathy in HELIOS Trial
7个月前
Breye Therapeutics Reports Promising Phase 1b Results for Oral Diabetic Retinopathy Drug Danegaptide
9个月前
Ocular Therapeutix Initiates HELIOS-3 Phase 3 Trial for AXPAXLI in Diabetic Retinopathy
去年
Vantage Biosciences Initiates Phase 2 Trial of Novel Oral Therapy for Diabetic Retinopathy
去年
Exonate Advances EXN407 Eye Drop to Phase IIb Trial for Diabetic Retinopathy Treatment
去年
Opus Genetics Gains FDA Agreement for Phase 3 Trial of APX3330 in Diabetic Retinopathy
2年前
OcuTerra's Nesvategrast Fails to Meet Primary Endpoint in Phase 2 Diabetic Retinopathy Trial
第 1 页,共 3 页
上一页
下一页